Live from the NIH registry
Studies recruiting near Albuquerque right now
Top 25 of 345 recruiting studies, sorted by proximity — each links to its official registry page
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
Phase 1, Phase 2
Interventional 242 participants sought
Presbyterian Kaseman Hospital (site 208) — Albuquerque, New Mexico (1.5 mi)
· Sponsor: VM Oncology, LLC
MDMA for Co-occurring PTSD and OUD After Childbirth
Stress Disorders, Post-Traumatic, Opioid Use Disorder
Phase 2
Interventional 15 participants sought
University of New Mexico Health Sciences — Albuquerque, New Mexico (1.5 mi)
· Sponsor: University of New Mexico
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma
Phase 1
Interventional 65 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
New Mexico Oncology Hematology — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Novartis Pharmaceuticals
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 270 participants sought
292 — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Corcept Therapeutics
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Sameek Roychowdhury
Parkinson's Foundation PD GENEration Genetic Registry
Parkinson's Disease
N/A
Observational 35,382 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Parkinson's Foundation
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: NRG Oncology
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
University of New Mexico — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Jaeb Center for Health Research
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Phase 3
Interventional 1,123 participants sought
University of New Mexico Comprehensive Cancer Center ( Site 6046) — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Inflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions Study
Decision-Making, Patient Care
Phase 2
Interventional 210 participants sought
University of New Mexico Health Sciences Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: University of Arkansas, Fayetteville
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Presbyterian Hospital — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Children's Oncology Group
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Raymond G. Murphy VA — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
Convergence Insufficiency, Traumatic Brain Injury
N/A
Interventional 100 participants sought
New Mexico VA Health Care System — Albuquerque, New Mexico (1.5 mi)
· Sponsor: New Jersey Institute of Technology
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
Albuquerque Clinical Trials (ACT) — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Ardelyx
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: NRG Oncology
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Velocity Clinical Research - Albuquerque — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
RSV Infection
Phase 3
Interventional 550 participants sought
Presbyterian Hospital — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Pfizer
Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
AMI Cardiogenic Shock
N/A
Observational 350 participants sought
New Mexico Heart — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Abiomed Inc.
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Lovelace Medical Center-Saint Joseph Square — Albuquerque, New Mexico (1.5 mi)
· Sponsor: NRG Oncology
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Presbyterian Hospital — Albuquerque, New Mexico (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Local Institution - 0381 — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 1,000 participants sought
University of New Mexico Cancer Center — Albuquerque, New Mexico (1.5 mi)
· Sponsor: Janssen Research & Development, LLC